Functional protein networks underlying T cell growth, proliferation and differentiation

T 细胞生长、增殖和分化的功能蛋白网络

基本信息

  • 批准号:
    10377132
  • 负责人:
  • 金额:
    $ 38.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-12-12 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary: Proper immune function is pivotal to the human health. CD4+ T cell is a central component of adaptive immunity to coordinate both innate and adaptive immune responses. Immune suppressive regulatory T (Treg) cells are pivotal in immune homeostasis and self-tolerance, and their function is controlled through quite diverse mechanisms, allowing Treg cells to respond appropriately to diverse environmental cues to ensure proper immune response. It is important to investigate the functional protein networks underlying T and Treg cell function in immune homeostasis and diseases. We have identified many critical factors, pathways, and mechanisms for T and Treg cell function in the last funding period, during which we revealed an unexpected critical role for an innate senor AIM2 (Absent In Melanoma 2) in controlling Treg cell function in a recent study. We found that AIM2 is expressed at much higher levels in Treg cells than in innate cells, in both human and mouse. TGFβ promotes AIM2 expression coinciding with Treg cell generation. Unlike Asc-/- and ICE-/- (caspase-1-/-11-/--) mice that are resistant to EAE, Aim2-/- mice developed more severe EAE than WT mice. AIM2 deletion leads to reduced Treg cell function during inflammatory diseases such as EAE. AIM2 is required for Treg cell stability to mitigate EAE. AIM2-deficiency leads to the hyper-activation of Akt-mTOR signaling to attenuate Treg cell function with altered immune metabolism. These exciting findings prompt us to hypothesize that the expression and function of AIM2 in Treg cells are controlled through mechanisms both distinct from and shared with those found in the innate cells, to uphold tolerance and restrain autoimmunity. To test this hypothesis, we strive to reach the following research aims. AIM 1: Reveal the genetic and molecular mechanisms of TGFβ promoted Aim2 expression in Treg cells. AIM 2: Investigate if AIM2 controls Treg cell function by integrating DNA-sensing function and inflammasome components. AIM 3: Mechanistic study of the functional AIM2-interacting protein network underlying AIM2 controlled Treg cell function. This proposed study will highlight a previously unappreciated critical role for AIM2 in Treg cells. It will revise the current paradigm for the function of AIM2 by incorporating its Treg cell specific function. It will provide new insights into how Treg cell generation and function can be regulated. It will shed new lights on the molecular networks underlying Treg cell function and to reveal potential novel molecular targets and therapies for autoimmune diseases.
Project Summary: Proper immune function is pivotal to the human health. CD4+ T cell is a central component of adaptive immunity to coordinate both innate and adaptive immune responses. Immune suppressive regulatory T (Treg) cells are pivotal in immune homeostasis and self-tolerance, and their function is controlled through quite diverse mechanisms, allowing Treg cells to respond appropriately to diverse environmental cues to ensure proper immune response. It is important to investigate the functional protein networks underlying T and Treg cell function in immune homeostasis and diseases. We have identified many critical factors, pathways, and mechanisms for T and Treg cell function in the last funding period, during which we revealed an unexpected critical role for an innate senor AIM2 (Absent In Melanoma 2) in controlling Treg cell function in a recent study. We found that AIM2 is expressed at much higher levels in Treg cells than in innate cells, in both human and mouse. TGFβ promotes AIM2 expression coinciding with Treg cell generation. Unlike Asc-/- and ICE-/- (caspase-1-/-11-/--) mice that are resistant to EAE, Aim2-/- mice developed more severe EAE than WT mice. AIM2 deletion leads to reduced Treg cell function during inflammatory diseases such as EAE. AIM2 is required for Treg cell stability to mitigate EAE. AIM2-deficiency leads to the hyper-activation of Akt-mTOR signaling to attenuate Treg cell function with altered immune metabolism. These exciting findings prompt us to hypothesize that the expression and function of AIM2 in Treg cells are controlled through mechanisms both distinct from and shared with those found in the innate cells, to uphold tolerance and restrain autoimmunity. To test this hypothesis, we strive to reach the following research aims. AIM 1: Reveal the genetic and molecular mechanisms of TGFβ promoted Aim2 expression in Treg cells. AIM 2: Investigate if AIM2 controls Treg cell function by integrating DNA-sensing function and inflammasome components. AIM 3: Mechanistic study of the functional AIM2-interacting protein network underlying AIM2 controlled Treg cell function. This proposed study will highlight a previously unappreciated critical role for AIM2 in Treg cells. It will revise the current paradigm for the function of AIM2 by incorporating its Treg cell specific function. It will provide new insights into how Treg cell generation and function can be regulated. It will shed new lights on the molecular networks underlying Treg cell function and to reveal potential novel molecular targets and therapies for autoimmune diseases.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yisong Wan其他文献

Yisong Wan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yisong Wan', 18)}}的其他基金

TGF-b superfamily signaling in controlling Th17 cell function in autoimmune neuroinflammation
TGF-b 超家族信号传导在控制自身免疫性神经炎症中 Th17 细胞功能
  • 批准号:
    10223523
  • 财政年份:
    2021
  • 资助金额:
    $ 38.55万
  • 项目类别:
TGF-b superfamily signaling in controlling Th17 cell function in autoimmune neuroinflammation
TGF-b 超家族信号传导在控制自身免疫性神经炎症中 Th17 细胞功能
  • 批准号:
    10539286
  • 财政年份:
    2021
  • 资助金额:
    $ 38.55万
  • 项目类别:
TGF-b superfamily signaling in controlling Th17 cell function in autoimmune neuroinflammation
TGF-b 超家族信号传导在控制自身免疫性神经炎症中 Th17 细胞功能
  • 批准号:
    10330037
  • 财政年份:
    2021
  • 资助金额:
    $ 38.55万
  • 项目类别:
Functional protein networks underlying T cell growth, proliferation and differentiation
T 细胞生长、增殖和分化的功能蛋白网络
  • 批准号:
    10657326
  • 财政年份:
    2016
  • 资助金额:
    $ 38.55万
  • 项目类别:
Functional protein networks underlying T cell growth, proliferation and differentiation
T 细胞生长、增殖和分化的功能蛋白网络
  • 批准号:
    9236809
  • 财政年份:
    2016
  • 资助金额:
    $ 38.55万
  • 项目类别:
Functional protein networks underlying T cell growth, proliferation and differentiation
T 细胞生长、增殖和分化的功能蛋白网络
  • 批准号:
    10064572
  • 财政年份:
    2016
  • 资助金额:
    $ 38.55万
  • 项目类别:
The roles of Gata3 in controlling Treg function
Gata3在控制Treg功能中的作用
  • 批准号:
    8649012
  • 财政年份:
    2012
  • 资助金额:
    $ 38.55万
  • 项目类别:
The roles of Gata3 in controlling Treg function
Gata3在控制Treg功能中的作用
  • 批准号:
    8373429
  • 财政年份:
    2012
  • 资助金额:
    $ 38.55万
  • 项目类别:
The roles of Gata3 in controlling Treg function
Gata3在控制Treg功能中的作用
  • 批准号:
    8462901
  • 财政年份:
    2012
  • 资助金额:
    $ 38.55万
  • 项目类别:
Roles for TAK1 in T cell development, function and tumorigenesis
TAK1 在 T 细胞发育、功能和肿瘤发生中的作用
  • 批准号:
    7636213
  • 财政年份:
    2008
  • 资助金额:
    $ 38.55万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.55万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了